An epidural neuroblastoma causing spinal cord compression in a 67-year-old woman by Jost, Gregory et al.
An epidural neuroblastoma
causing spinal cord compres-
sion in a 67-year-old woman
Gregory Jost,
1 Stephan Frank,
2
Nathalie Fischer,
3 Ethan Taub,
1
Luigi Mariani
1
1Department of Neurosurgery;
2Department of Neuropathology, Institute
of Pathology; 
3Department of Clinical
Oncology, University Hospital Basel,
Switzerland
Abstract 
We  report  a  case  of  disseminated
neuroblast  oma (NB) causing epidural spinal
cord  compression  in  a  67-year-old  woman.
Because NB is primarily a tumor of infancy
and childhood, less is known about its clinical
course and optimal treatment in adults. This
patient was treated with a thoracic laminecto-
my  and  tumor  resection;  polychemotherapy
with  one  cycle  of  vindesine,  cisplatin,  and
etoposide;  one  cycle  of  vincristine,  dacar-
bazine,  ifosfamide,  and  doxorubicin;  and
radiotherapy to the spine. She remained able
to walk but died 8.5 months later of diffuse sys-
temic tumor progression. 
Introduction
Neuroblastoma (NB) is a very rare tumor in
adults: fewer than 0.5% of cases are diagnosed
in  persons  over  the  age  of  20  years,
1 while
34.4% of cases are diagnosed in infants and
55% in children aged 1 to 10 years.
2 Treatment
algorithms have been established for children
and  adolescents,  but  optimal  therapeutic
strategies for the rare adult patients are not as
well  founded.  We  report  on  a  67-year-old
woman who presented with paraparesis owing
to an epidural metastasis of NB in the thoracic
spine. Signs and symptoms, magnetic reson  -
ance imaging (MRI), treatment, follow-up to
death, and autopsy findings are covered and
discussed in view of the current literature.
Case Report
Clinical manifestations and surgical
treatment
A 67-year-old woman was admitted to the
hospital with acute weakness and paresthesia
in both legs, and intermittent urinary reten-
tion, after having suffered thoracolumbar back
pain  for  two  months.  Physical  examination
revealed  a  spastic  paraparesis  affecting  the
proximal  more  than  the  distal  musculature,
hyperreflexia in the lower limbs, an ataxic gait,
and a T8 sensory level. The residual bladder
volume after micturition was 700 mL. MRI of
the spine revealed multifocal contrast-enhanc-
ing lesions in the vertebral body and preverte-
bral tissue of T4 and in the laminae and para  -
vertebral soft tissues of T6, T7, and T8 (Figure
1);  at  T7  and  T8  the  spinal  cord  was  com-
pressed by the epidural extension of the tumor.
Emergency  decompressive  surgery  was  per-
formed;  the  muscle-infiltrating  paravertebral
component  of  this  soft  tumor  was  removed
from T6 to T8 and the infiltrated T7 and T8
laminae were removed to expose the epidural
part of the tumor, which was lifted off the dura
en bloc. After surgery the patient’s paraparesis
improved  substantially,  and  she  was  able  to
walk with a walking frame. 
Pathology
Neuropathological analysis revealed a high-
ly cellular, mitotically active mass featuring a
lobular  histoarchitecture  (Figure  2A).  Small
undifferentiated round cells corresponding to
neuroblasts were dominant, whereas isolated
intermingled  cells  showed  features  of  gan-
glion-cell  differentiation  (Figure  2B).  No
prominent  Schwannian  stroma  component
was identified. The tumor focally invaded adja-
cent skeletal muscle (Figure 2C). Most of the
tumor cells were immunoreactive for synapto-
physin, neuron-specific enolase, and chromo-
granin  A,  confirming  neuronal  histogenesis
(Figure 2D and E). In addition, some cells with
ganglion-cell  differentiation  had  neurofila-
ment immunoreactivity (Figure 2F). Based on
these  findings,  a  NB  (Schwannian  stroma-
poor, undifferentiated subtype) was diagnosed.
The MYCN oncogene was not amplified.
Further clinical investigations and
treatment 
Postoperative thoraco-abdominal computed
tomography (CT) and single photon emission
computed  tomography  (SPECT)  revealed  a
small primary lesion in the left adrenal gland,
paravertebral soft tissue metastases at T4 and
T10, and multiple osseous metastases in the
left proximal humerus, left femur, and pelvis. 
Metaiodobenzylguanidine  (
131I-MIBG)  was
not a treatment option, because scintigraphy
showed  no  uptake.  The  patient  therefore
underwent  an  intensive  polychemotherapy
with curative intention, performed according
to  the  protocol  of  the  NB-2004  Study  of  the
German  Neuroblastoma  Group  (one  cycle  of
vindesine,  cisplatin,  and  etoposide  and  one
cycle  of  vincristine,  dacarbazine,  ifosfamide,
and  doxorubicin).  Unfortunately,  the  tumor
progressed  systemically  thereafter.  Palliative
locoregional radiotherapy with a total of 30 Gy
was directed at T2 to T11. A follow-up MRI after
four months showed that the vertebral metas-
tases had not progressed. Eight months after
surgery, the patient suffered from rapidly pro-
gressive dyspnea and a chest X-ray revealed
multiple pulmonary metastases. She died a few
days later. 
At autopsy, epidural tumor recurrence was
found at T7-T8, as well as disseminated dis-
ease in both lungs, tracheal and hilar lymph
nodes, liver, kidney, iliac crests, the vertebral
bodies of T4, T10, and L2, and the paraverte-
bral tissue adjacent to T10 (Figure 3).
Discussion
NB is primarily a tumor of infancy and child-
hood. It originates from migrating neural crest
cells destined for the adrenal medulla and sym-
pathetic  nervous  system.  Thus,  primary
lesions usually develop in the adrenal glands,
sympathetic  paraganglia  and  paravertebral
ganglia.
3 NB was, therefore, a highly unexpect-
ed finding in this 67-year-old woman. In fact,
the incidence of NB in adults aged 30 to 39
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years is only about 0.2 cases per million per-
sons per year.
2 Most primary NBs arise in the
adrenal  glands  (40%),  followed  by  the
abdomen  (25%).
1 Our  patient’s  disseminated
disease  probably  originated  in  an  adrenal
tumor. Many older patients, however, have pri-
mary NB in extra-abdominal locations: in two
single-institution series (16 patients aged 13
to  33  years  and  30  patients  aged  16  to  75
years), and in a literature review involving 57
patients aged 16 to 75 years, half of the pri-
mary NBs were found in extra-abdominal loca-
tions such as the thorax, pelvis, and neck.
4,5
The  best  treatment  of  NB  in  adults  is
unknown. After surgery, our patient received
two cycles of polychemotherapy according to
the pediatric protocol. Because of generalized
tumor progression, radiotherapy (30 Gy) was
given  for  locoregional  tumor  control  in  the
spine  (resulting  in  stable  disease  for  four
months). In another study, 21 Gy sufficed for
good  local  control  without  relapses  in  10
patients  who  were  followed  up  for  170+
months.
5
Many infants and children with NB do well
in the long term, but advanced age
6 and dis-
ease  stage,
7 MYCN  status  (amplified  versus
non-amplified  oncogene),
8 ploidy,
9 loss  of 
chromosome 1p,
10 and unfavorable histopathol-
ogy
11 predict a poorer outcome. One-third of all
adult NB patients have metastases at the time
of diagnosis (stage IV).
2 Among adult patients
(aged 20 years and older) with metastases in
one series, only 19.8% were alive 10 years after
diagnosis.
2 In  the  60-and-older  age  group
(stages I to IV), the 10-year survival was only
29%. 
MYCN amplification is found in 30-40% of
children with stage IV NB
12 but is uncommon
in  adult  patients.
4,5,13,14 In  the  present  case,
MYCN was not amplified. Advanced age also
independently  predicts  a  poor  outcome,
regardless of the MYCN amplification status.
Although a combination of surgery, radiother  -
apy, and high-dose chemotherapy
5 might pro-
duce the best results, the long-term prognosis
for adults with NB is still poor. 
MIBG  is  a  guanethidine  derivative,  struc-
turally  similar  to  norepinephrine,  that  is
expressed in sympathetic nervous tissue and
in tumors of neural crest origin. 
131I-MIBG has
been used with success for radionuclide ther -
apy of neural crest tumors since 1984. When
given as part of the multimodal therapy proto-
col, 
131I-MIBG may increase the potential cure
rate.
15 Some  authors  advise  the  use  of  cis-
retinoic acid, although there is no strong evi-
dence for its benefit.
16
NB is the malignant tumor that most fre-
quently  causes  spinal  cord  compression  in
children,
17 and was found in 5.2% of children
with  NB  aged  0  to  15  years.
18 Franks  et  al.
4
reported two adult patients with primary spinal
involvement  and  three  adolescent  patients
Figure  1.  (A)  Sagittal  T1-weighted  MRI  with  gadolinium  reveals  a  homogeneously
enhancing tumor in the posterior elements of T6 to T8 with epidural extension (arrow),
and in the T4 vertebral body and prevertebral soft tissue (arrowhead). (B) Axial T1-
weighted MRI with gadolinium shows severe compression of the spinal cord (asterisk) by
the tumor (arrowhead) and tumor mass in the spinous process and paravertebral muscu-
lature (arrows).
Figure 2. (A) Conventional hematoxylin-eosin staining reveals a cellular mass consisting
of small, mostly undifferentiated neuroblastic cells arranged in nests separated by deli-
cate stromal septae (100X magnification). (B) Some neuroblasts differentiating toward
ganglion cells are characterized by an eccentrically located nucleus with vesicular chro-
matin, a single, distinct nucleolus, and an increase of cytoplasm (arrows) (400X magni-
fication). (C) The tumor is seen invading the adjacent skeletal muscle (asterisk) (200X
magnification). (D) Immunohistochemical analysis reveals widespread expression of neu-
ronal differentiation markers such as synaptophysin (200X magnification) and (E) chro-
mogranin A (100X magnification). (F) Individual cells with ganglion-cell differentiation
express neurofilaments (arrows) (400X magnification).[page 76] [Rare Tumors 2010; 2:e27]
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(aged  15,  17,  and  18  years)  with  spinal
metastases.  The  two  patients  with  primary
spinal involvement were diagnosed at stage 2
disease  according  to  the  International
Neuroblastoma  Staging  System  (INSS  stage
2A:  localized  tumor  with  incomplete  gross
resection; stage 2B: localized tumor with com-
plete or incomplete gross resection and posi-
tive  ipsilateral  nonadherent  lymph  nodes).
19
One patient, aged 20 years, had NB of the tho-
racic spine, which was treated with surgery,
chemotherapy, and radiation. Clinical remis-
sion was maintained up to the last reported fol-
low-up 24 months after diagnosis. The second
patient, aged 33 years, was treated with sur-
gery and radiation for an epidural NB (level
not specified). Disease progressed after two
years and five months, and death ensued after
just over four years. In our case, acute para-
paresis  owing  to  dorsal  compression  of  the
spinal  cord  was  treated  with  emergency
laminectomy and tumor resection, a well-toler-
ated procedure in adults.
20 In children, howev-
er, spinal surgery or radiotherapy may cause
late spinal deform  ities.
21 This may be prevent-
ed by offering pediatric patients with epidural
compression chemo  therapy as first-line treat-
ment, which usually results in partial or even
full recovery of neurologic deficits. Hence, the
role of decompressive surgery as the first ther-
apy  step  has  come  under  debate.
22
Nevertheless, decompressive surgery can alle-
viate rapidly evolving paresis in children and
adults  or  improve  neurologic  functioning  of
pediatric  patients  with  poor  recovery  after
chemotherapy.
22
Conclusions
We have presented the case, management,
and follow-up of an elderly patient with spinal
cord  compression  by  disseminated  NB.  Our
multidisciplinary  approach  with  immediate
surgical  decompression  of  the  spinal  cord,
locoregional  radiotherapy,  and  systemic
chemotherapy controlled disease progress in
the spine so that the patient was able to recov-
er  partially  from  paraparesis  and  remained
able to walk. Despite combined therapy, how-
ever, NB in adults still has a poor prognosis for
survival.
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